Coya Therapeutics Inc. (COYA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Coya Therapeutics Inc.

    NASDAQ: COYA · Real-Time Price · USD
    6.27
    -0.11 (-1.72%)
    At close: Sep 05, 2025, 3:59 PM
    6.27
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    Coya Therapeutics Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 3.55M 6M n/a n/a
    Cost of Revenue
    		 n/a n/a 27.36K 16.13K
    Gross Profit
    		 3.55M 6M -27.36K -16.13K
    Operating Income
    		 -17.25M -7.9M -9.81M -4.87M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -15.6M -7.26M -12.24M -4.89M
    Net Income
    		 -14.88M -7.99M -12.24M -4.89M
    Selling & General & Admin
    		 8.89M 7.83M 4.85M 2.31M
    Research & Development
    		 11.89M 6.04M 4.41M 2.54M
    Other Expenses
    		 27K 28K 28K 16K
    Operating Expenses
    		 20.8M 13.91M 9.29M 4.87M
    Interest Expense
    		 n/a n/a 2.43M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 20.8M 13.91M 9.29M 4.87M
    Income Tax Expense
    		 -720K 723.85K n/a -21.48K
    Shares Outstanding (Basic)
    		 15.24M 10.16M 2.59M 9.68M
    Shares Outstanding (Diluted)
    		 15.24M 10.16M 2.59M 6.6M
    EPS (Basic)
    		 -0.98 -0.79 -4.73 -0.51
    EPS (Diluted)
    		 -0.98 -0.79 -4.73 -0.74
    EBITDA
    		 -17.22M -7.88M -12.22M -4.85M
    EBIT
    		 -17.23M -7.9M -12.24M -4.87M
    Depreciation & Amortization
    		 27.36K 27.36K 27.36K 16.13K

    Add to Watchlist